Cyrus Poonawalla, chairman of Covishield-maker Serum Institute of India (SII), Friday said he was opposed to the idea of mixing Covid vaccines as it might lead to a blame game between the drug manufacturers.
The efficacy of this approach has not been proven in field trials involving thousands of participants, Cyrus Poonawalla said
Cyrus Poonawalla, chairman of Covishield-maker Serum Institute of India (SII), Friday said he was opposed to the idea of mixing Covid vaccines as it might lead to a blame game between the drug manufacturers.
"I am against the mixing of two different vaccines. There is no need to mix two different vaccines," he said, when asked about a recent ICMR study that a cocktail of Covishield and Covaxin could generate better immunity.
"If cocktail vaccines are administered and if the result is not good, then SII may say that another vaccine was not good, vice versa, the other company might say that since you mixed Serum's vaccine, it did not give desired results," Poonawalla said.
The efficacy of this approach has not been proven in field trials involving thousands of participants, he added.
A study by the Indian Council of Medical Research involving 98 people, 18 of whom had inadvertently received Covishield as first dose and Covaxin as the second in Uttar Pradesh, showed that combining vaccines elicited better immunogenicity.
With PTI inputs